Your browser doesn't support javascript.
loading
Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing.
Chow, Signy; Kis, Olena; Mulder, David T; Danesh, Arnavaz; Bruce, Jeff; Wang, Ting Ting; Reece, Donna; Bhalis, Nizar; Neri, Paola; Sabatini, Peter Jb; Keats, Jonathan; Trudel, Suzanne; Pugh, Trevor J.
Afiliação
  • Chow S; University Health Network, Toronto, Canada.
  • Kis O; Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Mulder DT; University of Toronto, Toronto, Canada.
  • Danesh A; University Health Network, Toronto, Canada.
  • Bruce J; University Health Network, Toronto, Canada.
  • Wang TT; University Health Network, Toronto, Canada.
  • Reece D; University Health Network, Toronto, Canada.
  • Bhalis N; University Health Network, Toronto, Canada.
  • Neri P; University of Toronto, Toronto, Canada.
  • Sabatini PJ; University Health Network, Toronto, Canada.
  • Keats J; University of Toronto, Toronto, Canada.
  • Trudel S; University of Calgary, Calgary, Canada.
  • Pugh TJ; University of Calgary, Calgary, Canada.
Life Sci Alliance ; 6(1)2023 01.
Article em En | MEDLINE | ID: mdl-36328595
Multiple myeloma is a plasma cell neoplasm characterized by clonal immunoglobulin V(D)J signatures and oncogenic immunoglobulin gene translocations. Additional subclonal genomic changes are acquired with myeloma progression and therapeutic selection. PCR-based methods to detect V(D)J rearrangements can have biases introduced by highly multiplexed reactions and primers undermined by somatic hypermutation, and are not readily extended to include mutation detection. Here, we report a hybrid-capture approach (CapIG-seq) targeting the 3' and 5' ends of the V and J segments of all immunoglobulin loci that enable the efficient detection of V(D)J rearrangements. We also included baits for oncogenic translocations and mutation detection. We demonstrate complete concordance with matched whole-genome sequencing and/or PCR clonotyping of 24 cell lines and report the clonal sequences for 41 uncharacterized cell lines. We also demonstrate the application to patient specimens, including 29 bone marrow and 39 cell-free DNA samples. CapIG-seq shows concordance between bone marrow and cfDNA blood samples (both contemporaneous and follow-up) with regard to the somatic variant, V(D)J, and translocation detection. CapIG-seq is a novel, efficient approach to examining genomic alterations in myeloma.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article